Selective and Synergistic Activity of L-S,R-Buthionine Sulfoximine on Malignant Melanoma Is Accompanied by Decreased Expression of Glutathione-S-Transferase-Reference-Cited by-同舟云学术

Selective and Synergistic Activity of L-S,R-Buthionine Sulfoximine on Malignant Melanoma Is Accompanied by Decreased Expression of Glutathione-S-Transferase

Published:1997-08 Issue:4 Volume:10 Page:236-249
ISSN:0893-5785
Container-title:Pigment Cell Research
language:en
Short-container-title:Pigment Cell Res

Author:

FRUEHAUF JOHN P.,ZONIS SVETLANA,AL-BASSAM MOHAMMAD,KYSHTOOBAYEVA AINURA,DASGUPTA CHIRANJIB,MILOVANOVIC TATJANA,PARKER RICARDO J.,BUZAID ANTONIO C.

Publisher

Wiley

Subject

Cell Biology,Clinical Biochemistry,Developmental Biology,Plant Science,Agronomy and Crop Science

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1600-0749.1997.tb00490.x/fullpdf

Reference74 articles.

1. The Evaluation of Estrogen Receptor in Primary Breast Carcinoma by Computer-Assisted Image Analysis

2. Phase I clinical trial of intravenous L-buthionine sulfoximine and melphalan: an attempt at modulation of glutathione.

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Ferroptosis in Cancer Therapy: Mechanisms, Small Molecule Inducers, and Novel Approaches;Drug Design, Development and Therapy;2024-06

2. Targeting ferroptosis opens new avenues for the development of novel therapeutics;Signal Transduction and Targeted Therapy;2023-09-21

3. The therapeutic potential of targeting regulated non-apoptotic cell death;Nature Reviews Drug Discovery;2023-08-07

4. Reversal of cisplatin chemotherapy resistance by glutathione-resistant copper-based nanomedicine via cuproptosis;Journal of Materials Chemistry B;2022

5. Overcoming Cancer Cell Drug Resistance by a Folic Acid Targeted Polymeric Conjugate of Buthionine Sulfoximine;Anti-Cancer Agents in Medicinal Chemistry;2019-12-02